0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted]
testosterone enanthate
RxCUI: 2099686
What the CMS Formulary Data Shows for 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted]
Per the CMS 2026 Part D formulary file, 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted] (RxNorm concept RXCUI 2099686, generic name testosterone enanthate) appears on 5 distinct formulary files spanning 32 Medicare Part D plan offerings - 0.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 3 to Tier 4, with a cross-plan average of Tier 3.2.
Real-world access to 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 80% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 5,120 Part D beneficiaries filled 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted] in 2023, with total plan-and-beneficiary spending of $22,237,326 and an average per-beneficiary annual cost of $4,343.23. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted] today.
Coverage Details
- Formularies covering
- 5
- Plans covering
- 32
- Coverage rate
- 0.6%
- Tier range
- Tier 3 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 80% of formularies
2023 Medicare Spending
- Beneficiaries
- 5,120
- Total spending
- $22,237,326
- Avg per beneficiary
- $4,343.23
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted]
32 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST | T3 | Yes | $0 | NV |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST | T3 | Yes | $0 | NV |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST | T3 | Yes | $0 | NV |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST | T3 | Yes | $0 | NV |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST | T3 | Yes | $0 | NV |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T3 | Yes | $0 | FL |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T3 | Yes | $0 | FL |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Beyond (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Beyond (HMO-POS) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T3 | Yes | $0 | FL |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST | T3 | Yes | $0 | NV |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T3 | Yes | $0 | FL |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Diabetes and Heart Care Plus (HMO C-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $0 | TX |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST | T3 | Yes | $4.20 | NV |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T3 | Yes | $4.80 | FL |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | Yes | $4.80 | TX |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST | T3 | Yes | $9.50 | NV |
| Keystone 65 Select Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T4 | Yes | $47.00 | PA |
| Keystone 65 Preferred Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T4 | Yes | $59.70 | PA |
| Keystone 65 Select Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T4 | Yes | $63.50 | PA |
| Keystone 65 Preferred Rx (HMO) | KEYSTONE HEALTH PLAN EAST, INC. | T4 | Yes | $79.70 | PA |
| Personal Choice 65 Rx (PPO) | QCC INSURANCE COMPANY | T4 | Yes | $102.20 | PA |
| Personal Choice 65 Rx (PPO) | QCC INSURANCE COMPANY | T4 | Yes | $112.70 | PA |
Frequently Asked Questions
Is 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted] covered by Medicare Part D?
Yes, 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted] is covered by 32 Medicare Part D plans (0.6% of all Part D formularies).
What tier is 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted] on Medicare Part D plans?
0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted] averages Tier 3.2 across Part D plans, ranging from Tier 3 to Tier 4.
Does 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted] require prior authorization?
100% of Part D formularies require prior authorization for 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted]. Step therapy: 0%. Quantity limits: 80%.
How much does Medicare spend on 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted]?
In 2023, total Medicare Part D spending on 0.5 ML testosterone enanthate 200 MG/ML Auto-Injector [Xyosted] was $22,237,326, covering 5,120 beneficiaries. The average spend per beneficiary was $4,343.23.
Read our methodology - how this data is sourced, computed, and verified.